Association of β2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels
Open Access
- 26 October 2005
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 14 (1) , 94-100
- https://doi.org/10.1038/sj.ejhg.5201521
Abstract
Adrenergic receptors regulate lipid mobilization, energy expenditure and glycogen breakdown. The β2 adrenergic receptor (β2-AR) gene may constitute a potential candidate gene to explain part of the genetic predisposition to human obesity and correlated traits. With regard to the association between β2-AR gene polymorphisms and obesity-related metabolic disorders, published reports give conflicting results. We investigated the role of three polymorphisms, and related haplotypes of the β2-AR in the obesity and related traits in a cohort of overweight/obese subjects. We characterized one single nucleotide polymorphism (SNP) in the promoter region (5′LC-Cys19Arg) and two in the coding region (Gly16Arg and Gln27Glu) of the β2-AR in 642 consecutively recruited overweight/obese subjects in whom extensive clinical and biochemical analysis was performed. The effect of the polymorphisms on quantitative variables was investigated using multiple linear regression analysis. 5′LC-Cys19 homozygous showed higher triglyceride and LDL-cholesterol levels compared to 5′LC-Arg19 homozygous (P=0.03 and P=0.01, respectively). Similar increase in triglyceride and LDL-cholesterol levels was observed for Arg/Arg genotype compared to Gly/Gly genotype of Gly16Arg polymorphism (P=0.02 and P=0.01, respectively) and for Gln/Gln genotype compared to Glu/Glu genotype of the Gln27Glu polymorphism (P=0.01 and P=0.03, respectively). The 5′LC-Cys19Arg16Gln27 haplotype determined a significant increase in triglyceride and LDL-cholesterol levels compared to 5′LC-Arg19Gly16Glu27 haplotype (P=0.05 and P=0.02, respectively). Our findings provide additional weight to previous observations on the influence of these three genetic variants on lipid phenotypes; particularly on the increase of triglycerides and LDL-cholesterol levels in overweight/obese subjects carrying the 5′LC-Cys19Arg16Gln27 haplotype.Keywords
This publication has 37 references indexed in Scilit:
- β2 Adrenoceptor Functional Gene Variants, Obesity, and Blood Pressure Level Interactions in the General PopulationHypertension, 2003
- The Gly16→Arg16and Gln27→Glu27Polymorphisms of β2-Adrenergic Receptor Are Associated with Metabolic Syndrome in MenJournal of Clinical Endocrinology & Metabolism, 2003
- Polymorphism of the β2-Adrenergic Receptor Gene and Desensitization in Human Airway Smooth MuscleAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Pharmacogenetics of Beta-1- and Beta-2-Adrenergic ReceptorsPharmacology, 2000
- The role of β2-adrenergic receptor variation in human hypertensionCurrent Hypertension Reports, 2000
- Association of polymorphisms in the ?2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus (Short Communication)Diabetologia, 1999
- Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression.Journal of Clinical Investigation, 1998
- Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.Diabetes, 1998
- Adrenergic Receptors — Evolving Concepts and Clinical ImplicationsNew England Journal of Medicine, 1996
- Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.American Journal of Respiratory Cell and Molecular Biology, 1995